Are genetic variants in the TEP1 gene associated with prostate cancer risk and recurrence?
These data suggest that genetic variations in the TEP1 gene may be biomarkers for risk of PCa and BCR after RP.
Our findings suggest that an E-SBPRE is frequent among prehypertensive subjects and is associated with cardiovascular remodeling, which may herald cardiovascular disease.